We have a wide range of products for research and diagnostics of lab-based and rapid point-of-care assays.
- Monoclonal and polyclonal antibodies
- Recombinant proteins
- Flagellins
- COVID19 ELISA assays
- LYME DISEASE assays (IN PROGRESS)
- TYPE1 DIABETES assays (IN PROGRESS)
ANTIBODIES
We have a large panel of antibodies towards Human, Rodent, Bovine, Canis, Equus, Ovis, Fish, Porcine, Parasite and Viral protein targets . Due to our unique method, our antibodies are designed to overlap multiple animal species increasing their value and broaden their application in the medical and veterinary fields.
RECOMBINANT PROTEINS
We have a large panel of recombinant proteins mainly for veterinary research. Our protfolio inlcudes fish cytokines, viral proteins and bacterial markers.
FLAGELLINS
We have generated a panel of 30 bioactive flagellins to a broad range of bacterial species, all of which to be made available to forward research and vaccine development.
COVID-19 ASSAYS
At a population level, the humoral response to SARS-CoV-2 is heterogeneous. Therefore, traditional antibody assays using either the spike or nucleocapsid as antigens are less sensitive. We offer UNIVERSAL ASSAY for detection of antibody response to SARS-CoV-2 resulting from vaccination and/or infection, and DIFFERENTIAL ASSAY to differentiate between humoral responses to vaccination and primary infection with SARS-CoV-2.
LYME DISEASE ASSAYS
In progress! For enquiries and orders please contact us: info@epitogenx.com
TYPE 1 DIABETES ASSAYS
In progress! For enquiries and orders please contact us: info@epitogenx.com
REAGENTS
We have a range of in-house reagents that can be used in research and diagnostic assay development including blocking reagents and folding buffer. The catalogue will be made available soon. For enquiries and orders please contact us: info@epitogenx.com
